Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (407)

Name Institution Why
Kenneth Carl Anderson, M.D.Dana-Farber Cancer Institute Why?
Turgay Dalkara, PH.D., M.D.Massachusetts General Hospital Why?
Michael Arthur Moskowitz, M.D.Massachusetts General Hospital Why?
Alfred Lewis Goldberg, Ph.D.Harvard Medical School Why?
Per-Olof Hasselgren, PH.D., M.D.Beth Israel Deaconess Medical Center Why?
Andrew Baker, Ph.D.Massachusetts General Hospital Why?
Horst Christian Weber, M.D.Veterans Affairs Boston Healthcare System Why?
Paul Gerard Guy Richardson, M.B.,B.S.Dana-Farber Cancer Institute Why?
Jacob Laubach, M.D.Dana-Farber Cancer Institute Why?
Mien Van Hoang, Ph.D.Massachusetts Eye and Ear Infirmary Why?
Giada Bianchi, M.D.Dana-Farber Cancer Institute Why?
Teru Hideshima, Ph.D., M.D.Dana-Farber Cancer Institute Why?
Harold Fisher Dvorak, M.D.Beth Israel Deaconess Medical Center Why?
Sule Cataltepe, M.D.Brigham and Women's Hospital Why?
Jaehong Suh, PH.D.Massachusetts General Hospital Why?
Per Page    Page  of 28last Nextnext
Search Criteria
  • Cysteine Proteinase Inhibitors
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.